Loading chat...

NY A02534

Bill

Status

Introduced

1/17/2025

Primary Sponsor

John McDonald

Click for details

Origin

Assembly

2025-2026 General Assembly

AI Summary

  • Licensed pharmacists may initiate treatment for COVID-19, influenza, and strep throat (Group A streptococcal infection) following a positive test result, under a statewide protocol developed by the Department of Health

  • Pharmacists must ask patients if they have a primary care provider and maintain an updated list of local primary care providers to give patients who lack one

  • The Department of Health must maintain a searchable online list of primary care providers by zip code, including federally qualified health centers, providers serving Medicaid and low-income patients, and information on cultural and linguistic capabilities

  • Pharmacists must retain records of test results and treatment, and report this information to the patient's designated physician, physician assistant, or nurse practitioner unless the patient directs otherwise

  • The law takes effect immediately and automatically expires on April 1, 2028

Legislative Description

Provides for the initiation of treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection by a licensed pharmacist in certain circumstances.

Last Action

referred to higher education

1/7/2026

Committee Referrals

Higher Education1/17/2025

Full Bill Text

No bill text available